Roche's Tamiflu follow-up Xofluza scores in flu-spreading study
Fierce Pharma,
With Tamiflu sales crumbling, Roche has pivoted to next-gen flu med Xofluza as a follow-up to the aging blockbuster.
Five years of non-prescription oseltamivir: effects on resistance, immunization and stockpiling
Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), September 2012
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Readers on
- mendeley
- 40 Mendeley